CY2283B1 - Use of vincristine for the evaluation of substances at the neuroral level - Google Patents
Use of vincristine for the evaluation of substances at the neuroral levelInfo
- Publication number
- CY2283B1 CY2283B1 CY0200037A CY0200037A CY2283B1 CY 2283 B1 CY2283 B1 CY 2283B1 CY 0200037 A CY0200037 A CY 0200037A CY 0200037 A CY0200037 A CY 0200037A CY 2283 B1 CY2283 B1 CY 2283B1
- Authority
- CY
- Cyprus
- Prior art keywords
- substances
- vincristine
- evaluation
- level
- neuroral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9006399A FR2662355B1 (fr) | 1990-05-22 | 1990-05-22 | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
Publications (1)
Publication Number | Publication Date |
---|---|
CY2283B1 true CY2283B1 (en) | 2003-07-04 |
Family
ID=9396855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY0200037A CY2283B1 (en) | 1990-05-22 | 2002-05-15 | Use of vincristine for the evaluation of substances at the neuroral level |
Country Status (17)
Country | Link |
---|---|
US (3) | US5229389A (xx) |
EP (2) | EP0655247B1 (xx) |
JP (2) | JP2618115B2 (xx) |
KR (1) | KR0181330B1 (xx) |
AT (2) | ATE207747T1 (xx) |
BR (1) | BR9105015A (xx) |
CA (2) | CA2365832C (xx) |
CY (1) | CY2283B1 (xx) |
DE (2) | DE69132797T2 (xx) |
DK (2) | DK0458696T3 (xx) |
FR (1) | FR2662355B1 (xx) |
HK (1) | HK1001471A1 (xx) |
HU (1) | HU208922B (xx) |
IE (1) | IE911707A1 (xx) |
IL (3) | IL112167A (xx) |
TW (1) | TW216771B (xx) |
ZA (1) | ZA913865B (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0192386A (ja) * | 1987-10-05 | 1989-04-11 | Hitachi Ltd | 密閉循環型吸収式冷凍機及び吸収式冷凍機用吸収液 |
FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
US5618822A (en) * | 1990-05-23 | 1997-04-08 | Sanofi | N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
FR2662442A1 (fr) * | 1990-05-23 | 1991-11-29 | Midy Spa | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. |
US5557209A (en) * | 1990-12-20 | 1996-09-17 | Hewlett-Packard Company | Identification of pin-open faults by capacitive coupling through the integrated circuit package |
FR2690158B1 (fr) * | 1992-04-17 | 1994-07-22 | Sanofi Elf | Nouveau derive arylpiperidinique, procede pour sa preparation et compositions pharmaceutiques le contenant. |
FR2702656B1 (fr) * | 1993-03-18 | 1995-06-16 | Sanofi Elf | Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs. |
US5698565A (en) * | 1995-06-09 | 1997-12-16 | Hoffmann-La Roche Inc. | Use of phenoxy-pyridine derivatives |
FR2736053B1 (fr) * | 1995-06-28 | 1997-09-19 | Sanofi Sa | Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
JP3468526B2 (ja) * | 1995-10-26 | 2003-11-17 | サノフィーサンテラボ | 筋萎縮性側索硬化症治療薬調製のための1−(2−ナフタ−2−イルエチル)−4−(3−トリフルオロメチルフェニル)−1,2,3,6−テトラヒドロピリジンの使用 |
FR2740343B1 (fr) * | 1995-10-26 | 1999-01-22 | Sanofi Sa | Utilisation de la 1-(2-napht-2-yl-ethyl)-4- (3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique |
DE69736976T2 (de) * | 1996-03-29 | 2007-10-18 | Trustees Of Boston University, Boston | Mit Alzheimer Krankheit verknüpften Verfahren zur Diagnose, zur Herstellung von Medikamenten und zum Screenen von Substanzen sowie aus Beta-Amyloid abgeleiteten Peptiden |
US5891465A (en) * | 1996-05-14 | 1999-04-06 | Biozone Laboratories, Inc. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
FR2757160B1 (fr) * | 1996-12-13 | 1999-03-12 | Sanofi Sa | 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
FR2757161B1 (fr) * | 1996-12-13 | 1999-03-12 | Sanofi Sa | Diphenylalkyl-tetrahydropyridines |
FR2757510B1 (fr) * | 1996-12-23 | 2000-01-07 | Sanofi Sa | Forme microparticulaire d'un derive de tetrahydropyridine |
FR2757512B1 (fr) * | 1996-12-24 | 1999-03-12 | Sanofi Sa | Utilisation de benzoylalkyl-1-1,2,3,6-tetrahydropyridines |
EP0954311A1 (fr) * | 1997-02-03 | 1999-11-10 | Sanofi-Synthelabo | Utilisation du 1- 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1yl]-2-(6,7-dimethoxynapht-2-yl)ethane pour la preparation de medicaments destines aux traitements de troubles cerebraux et neuronaux |
FR2762514B1 (fr) | 1997-04-29 | 1999-10-22 | Sanofi Sa | Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation |
FR2763847B1 (fr) * | 1997-05-28 | 2003-06-06 | Sanofi Sa | Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1 |
CO4980891A1 (es) * | 1997-11-14 | 2000-11-27 | Sanofi Sa | Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer |
FR2771007B1 (fr) * | 1997-11-14 | 2000-12-01 | Sanofi Sa | Association de principes actifs pour le traitement de la demence senile du type alzheimer |
DE19751949A1 (de) * | 1997-11-24 | 1999-05-27 | Bayer Ag | Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration |
TWI237035B (en) * | 1998-07-24 | 2005-08-01 | Polyplastics Co | Polyacetal copolymer |
KR101130212B1 (ko) * | 2002-03-27 | 2012-04-13 | 파이토팜 피엘씨 | 사포게닌 및 그 유도체의 치료 방법 및 사용법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2531707A1 (fr) * | 1982-08-16 | 1984-02-17 | Midy Spa | Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques |
FR2639226B1 (fr) * | 1988-11-18 | 1993-11-05 | Sanofi | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs |
FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
-
1990
- 1990-05-22 FR FR9006399A patent/FR2662355B1/fr not_active Expired - Lifetime
-
1991
- 1991-05-17 IL IL11216791A patent/IL112167A/en not_active IP Right Cessation
- 1991-05-17 IL IL9817591A patent/IL98175A/en not_active IP Right Cessation
- 1991-05-20 TW TW080103889A patent/TW216771B/zh not_active IP Right Cessation
- 1991-05-20 IE IE170791A patent/IE911707A1/en not_active IP Right Cessation
- 1991-05-21 AT AT94403014T patent/ATE207747T1/de not_active IP Right Cessation
- 1991-05-21 EP EP94403014A patent/EP0655247B1/fr not_active Expired - Lifetime
- 1991-05-21 CA CA002365832A patent/CA2365832C/en not_active Expired - Fee Related
- 1991-05-21 DK DK91401311.5T patent/DK0458696T3/da active
- 1991-05-21 US US07/703,835 patent/US5229389A/en not_active Expired - Lifetime
- 1991-05-21 DK DK94403014T patent/DK0655247T3/da active
- 1991-05-21 EP EP91401311A patent/EP0458696B1/fr not_active Expired - Lifetime
- 1991-05-21 DE DE69132797T patent/DE69132797T2/de not_active Expired - Fee Related
- 1991-05-21 DE DE69115989T patent/DE69115989T2/de not_active Expired - Lifetime
- 1991-05-21 CA CA002042974A patent/CA2042974C/en not_active Expired - Lifetime
- 1991-05-21 AT AT91401311T patent/ATE132369T1/de not_active IP Right Cessation
- 1991-05-22 HU HU911729A patent/HU208922B/hu unknown
- 1991-05-22 JP JP3146949A patent/JP2618115B2/ja not_active Expired - Lifetime
- 1991-05-22 KR KR1019910008272A patent/KR0181330B1/ko not_active IP Right Cessation
- 1991-05-22 ZA ZA913865A patent/ZA913865B/xx unknown
- 1991-11-07 US US07/789,044 patent/US5270320A/en not_active Expired - Lifetime
- 1991-11-19 BR BR919105015A patent/BR9105015A/pt not_active Application Discontinuation
-
1993
- 1993-10-20 US US08/142,069 patent/US5468753A/en not_active Expired - Lifetime
-
1994
- 1994-12-27 IL IL11216794A patent/IL112167A0/xx unknown
-
1996
- 1996-08-20 JP JP8218926A patent/JP2954029B2/ja not_active Expired - Fee Related
-
1998
- 1998-01-20 HK HK98100449A patent/HK1001471A1/xx not_active IP Right Cessation
-
2002
- 2002-05-15 CY CY0200037A patent/CY2283B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW216771B (xx) | ||
DE69100547T2 (de) | Methode und Vorrichtung zum elektrochemischen Bearbeiten der Spritzöffnungen von Brennstoff-Einspritzdüsen. | |
DE3177156D1 (de) | Guanin-verbindungen und ihre verwendung zur herstellung eines antivirusmittels. | |
DE69008705T2 (de) | Aufzeichnungsflüssigkeit und Verfahren zur Tintenstrahl-Aufzeichnung mit dieser Flüssigkeit. | |
IT8124138A0 (it) | Procedimento e apparecchio per determinare quantitativamente il livello di emoglobina in campioni biologici. | |
DE68906545T2 (de) | Verfahren zum melken eines tieres. | |
DE3280085D1 (de) | Verfahren und vorrichtung zum aktivieren von aktivkohle. | |
AT383491B (de) | Vorrichtung zum verabreichen von voll- oder sitz- baedern, insbesondere unter verwendung von peloid | |
DE59000468D1 (de) | Verfahren zur schnellen pruefung der wirksamkeit von agenzien auf mikroorganismen. | |
DE69107203T2 (de) | Wirbelbettverfahren zum imprägnieren von fasern mit polymer-pulvern und vorrichtung dafür. | |
DE3879754D1 (de) | Hydrophiler zusatz zum zuechten von pilzen und verfahren zu seiner verwendung. | |
DE58905617D1 (de) | Verfahren zur Überwachung und/oder Regelung eines Spritzgiessprozesses. | |
DE69003569D1 (de) | Carbonsaeureester, verfahren zu ihrer herstellung und sie als wirkstoff enthaltende insektizide und/oder acarizide. | |
DE3575122D1 (de) | Vorrichtung zum belueften von stroemenden medien. | |
DE68903554T2 (de) | Verfahren zur verminderung der axialen dispersion in einem von einem magnetfeld stabilisierten wirbelbett. | |
ATE9343T1 (de) | 2,6-diethyl-3,5-dimethyl-2,3-dihydro-4h-pyran, verfahren zu seiner herstellung und seine verwendung zur frueherkennung, lokalisierung und bekaempfung von lasioderma serricorne f. | |
DE3669159D1 (de) | Triazinderivate, verfahren zur herstellung dieser derivate und herbizide, welche diese derivate als wirksame komponente enthalten. | |
DE3871671T2 (de) | Verfahren zum herstellen von uran- und/oder plutoniumnitrid, verwendbar als kernbrennstoffmaterial. | |
ATE12929T1 (de) | 3-halogenalkoxy-4-nitro-2'-chlor-4'trifluormethyl-diphenyl|ther, verfahren zu deren herstellung, sie enthaltende mittel sowie deren verwendung als herbizide. | |
Larson | An analysis of the effectiveness of instruction in strategies for studying at the grade five, seven and eight level | |
ATA393181A (de) | Verfahren und vorrichtung zum herstellen von brennstoff-briketts oder -pellets aus muell | |
ATE21349T1 (de) | Verfahren und vorrichtung zum zusammensetzen von moebeln. | |
ATE32830T1 (de) | Verfahren und system zur ermittlung des physiologischen status. | |
ATE105312T1 (de) | Aufzeichnungsfluessigkeit und verfahren zur tintenstrahl-aufzeichnung mit dieser fluessigkeit. | |
MX9203737A (es) | Metodo para establecer niveles de sangre de biocida en enimales y sistema de dosificacion y metodo para usar el mismo. |